• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX SANTA ROSA OVATION IX; MAIN BODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX SANTA ROSA OVATION IX; MAIN BODY Back to Search Results
Model Number TV-AB3480-J
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 08/30/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device involved in this event will not be returned for evaluation as it remains implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event or Problem Description
The patient was initially implanted with an ovation ix main body and two (2) iliac limb stent grafts to treat an abdominal aortic aneurysm (aaa).Approximately one (1) month post initial procedure a type 1a endoleak was found on the 30 day follow up.The patient is stable and the physician plans to re-intervene.
 
Additional Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.There are no other equivalent adverse events/incidents for this lot number existing within the endologix complaint handling system.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted in the patient.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the type ia endoleak is confirmed.This is consistent with the reported adverse event/incident.Procedure related harms, device, user, procedure or anatomy relatedness of this complaint could not be determined with the medical records available for review.It should be noted that the second sealing ring is slightly in the fusiform sac; however, the aortic body and first sealing ring are according to the ifu and this case is on-label.During the investigation and with the information available, endologix found no evidence to suggest the device was used off-label.The final patient status was reported be good following a successful secondary endovascular procedure.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.
 
Event or Problem Description
The patient was initially implanted with an ovation ix main body and two (2) iliac limb stent grafts to treat an abdominal aortic aneurysm (aaa).Approximately one (1) month post initial procedure a type 1a endoleak was found on the 30 day follow up.The patient is stable and the physician plans to re-intervene.Subsequent to the initial report, additional information was provided that successful re-intervention was completed with implant of a palmaz (non-endologix) stent and ballooning.The final patient status was reported to be well.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Common Device Name
MAIN BODY
Manufacturer (Section D)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
santa rosa CA 95403
MDR Report Key10614062
Report Number3008011247-2020-00109
Device Sequence Number14204153
Product Code MIH
UDI-Device IdentifierM701TVAB3480J1
UDI-Public+M701TVAB3480J1/$$3230430FS042920081
Combination Product (Y/N)N
Initial Reporter StateIL
PMA/510(K) Number
P120006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 09/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/30/2023
Device Model NumberTV-AB3480-J
Device Catalogue NumberTV-AB3480-J
Device Lot NumberFS042920-08
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 09/09/2020
Supplement Date Received by Manufacturer12/02/2020
Initial Report FDA Received Date10/01/2020
Supplement Report FDA Received Date12/02/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
FILL POLYMER FF021120-03.; ILIAC LIMB FS040120-14.; ILIAC LIMB FS040820-43.; FILL POLYMER FF021120-03; ILIAC LIMB FS040120-14; ILIAC LIMB FS040820-43
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient Age71 YR
-
-